SCHEMBL30210962

SCHEMBL30210962

COc1ccc(-c2cc(C(=O)c3sc(N(c4ccc(F)cc4)[C@H](C)C(N)=O)nc3N)on2)cn1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 2/20 0.38
PTPN1 P18031 1/20 0.36
MEN1 O00255 2/20 0.35
KMT2A Q03164 2/20 0.35
NPC1 O15118 1/20 0.35
GRM2 Q14416 1/20 0.34
FPR2 P25090 1/20 0.34
SCN9A Q15858 1/20 0.34
KCNH2 Q12809 1/20 0.34
NTRK1 P04629 1/20 0.33
CSF1R P07333 1/20 0.33
NTRK2 Q16620 1/20 0.33
FGFR1 P11362 1/20 0.33
FGFR2 P21802 1/20 0.33
FGFR4 P22455 1/20 0.33
FGFR3 P22607 1/20 0.33
CDK5 Q00535 1/20 0.33
CDK5R1 Q15078 1/20 0.33
CSGALNACT1 Q8TDX6 1/20 0.33
OXTR P30559 3/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23930466 1.00 MAPT (0.38) MAPTPTPN1MEN1KMT2ANPC1
SCHEMBL23930475 0.86 NPC1 (0.38) MAPTPTPN1MEN1KMT2ANPC1
SCHEMBL30210882 0.86 NPC1 (0.38) MAPTPTPN1MEN1KMT2ANPC1
SCHEMBL23930626 0.86 MEN1 (0.44) MAPTPTPN1MEN1KMT2ACDK5
SCHEMBL23930490 0.86 MEN1 (0.44) MAPTPTPN1MEN1KMT2ACDK5
SCHEMBL23930461 0.86 MEN1 (0.44) MAPTPTPN1MEN1KMT2ACDK5
SCHEMBL30210845 0.86 CDK5 (0.39) MAPTPTPN1MEN1KMT2ANPC1
SCHEMBL23930581 0.86 CDK5 (0.39) MAPTPTPN1MEN1KMT2ANPC1
SCHEMBL23930641 0.85 CDK5 (0.41) MAPTMEN1KMT2ACDK5CDK5R1
SCHEMBL30210764 0.85 CDK5 (0.41) MAPTMEN1KMT2ACDK5CDK5R1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4139287-B1 SUBSTITUTED AMINOTHIAZOLES AS DGKZETA INHIBITORS FOR IMMUNE ACTIVATION BAYER AG (DE) 2025-02-26 EP claimed
EP-4139287-A1 SUBSTITUTED AMINOTHIAZOLES AS DGKZETA INHIBITORS FOR IMMUNE ACTIVATION Bayer Aktiengesellschaft (DE) 2023-03-01 EP claimed
EP-4139287-A1 SUBSTITUTED AMINOTHIAZOLES AS DGKZETA INHIBITORS FOR IMMUNE ACTIVATION Bayer Aktiengesellschaft (DE) 2023-03-01 EP disclosed